Growing Up on a Farm; Making Strides in a Lab | Meet a Scientist
What do the fur patterns of tigers have to do with advances in ovarian cancer treatment? Juan Cubillos-Ruiz, PhD, an OCRA grantee, grew up on a farm near Bogota, Colombia. … Continued
News
PARP Inhibitors in Ovarian Cancer Treatment: What’s Next?
(February 13, 2020) PARP inhibitors have shown to be a promising treatment option for a subset of ovarian cancer patients. As of February 2020, there are currently 3 FDA-approved PARP … Continued
Conversation on Link Between Talcum Powder and Ovarian Cancer Continues with New Prospective Study
(January 15, 2020) A new study in the Journal of the American Medical Association (JAMA) found no statistically significant association between self-reported use of powder in the genital area and … Continued
OCRA Awards $6.6 Million in Ovarian Cancer Research Grants for 2020
(January 13, 2020) Thanks to your support, 22 top scientists at 19 eminent medical centers across the world will delve into important topics across the ovarian cancer landscape. In 2020, … Continued
OCRA-Funded Research Advances Immunotherapy
(December 23, 2019) OCRA-funded scientist Dr. Sarah Gitto is making strides toward better harnessing the immune system to fight ovarian cancer. As reported recently in Gynecologic Oncology, Dr. Gitto and … Continued
OCRA-Funded Research Breakthroughs in 2019
OCRA-funded scientists have been hard at work this year, uncovering breakthroughs in ovarian cancer prevention, diagnostics, and treatment that can save women’s lives. Our grantees have made incredible progress toward … Continued
OCRA Research Reveals Two Cells of Origin for High Grade Ovarian Cancer
(December 3, 2019) The origins of high grade serous ovarian carcinoma (HGSOC) is a debated topic in the scientific community. Prior research has suggested the cancer arises from the fallopian … Continued
OCRA-Funded Research Yields Insight into Clear Cell Ovarian Cancers
(November 13, 2019) A study recently published in Nature Communications and led by OCRA grantee Dr. Rugang Zhang showed that the ARID1A protein plays a fundamental role in ensuring correct … Continued
IUD May Lower Risk of Developing Ovarian Cancer
(November 6, 2019) A recent research review conducted by a team at the University of Colorado Anschutz, and published this month by the American College of Obstetrics and Gynecology, found … Continued
OCRA-Funded Research Explores New Pathways for Understanding Metastases
In an effort to further understand disease initiation and progression, OCRA grantee Dr. Sumegha Mitra, along with colleagues at Indiana University, conducted research which revealed key changes in gene expression … Continued
PARP Inhibitor and Chemotherapy Combination Improves Progression-Free Survival
(October 7, 2019) Published recently in the New England Journal of Medicine, a group of investigators led by OCRA Scientific Advisory Committee member Dr. Robert Coleman found an innovative combination … Continued
OCRA-Funded Research Elucidates New Immunotherapy Approach
(September 19, 2019) While harnessing the immune system has resulted in strong responses for a subset of cancer patients, the majority of patients have remained unresponsive to this approach. In … Continued